
Pulmotect
Developer of a respiratory therapeutics technology intended to reduce morbidity and mortality in patients at risk of severe respiratory diseases. The company's therapeutics technology stimulates the b...
Valuation
$59.3M
Latest known
Share Price
N/A
Total Raised
$29.5M
Last Round
N/A